Fetal-Cell Revival for Parkinson's Disease
the Psychiatry Advisor take:
For the first time in 10 years, a team of neurosurgeons this month will transplant cells from aborted fetuses into the brain of a person suffering from Parkinson's disease. The moratorium on replacement-therapy trials began in 2003 since trials involving the therapy were inconcklusive up to that point and the results were difficult to interpret.
The group, known as the Parkinson’s Disease Global Force, includes scientists from the European, US and Japanese teams about to embark on the trials.
More than 100 patients worldwide received the therapy as part of clinical trials before the moratorium. “But centers used different procedures and protocols — it was impossible to work out why some patients did very well and others didn’t benefit at all,” says neurologist Roger Barker at the University of Cambridge, UK, a member of working group.
The stem cell transplants will break a decade-long international moratorium on the controversial therapy.
Fetal-cell revival for Parkinson's
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Nomophobia: The Modern-Day Pathology
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Prazosin May Be Effective as Treatment for Alcohol Use Disorder
- Text Message Reminders Improve Medication Adherence in Bipolar I Disorder
- Improving Medication Adherence in ADHD Lowers Risk for Oppositional Defiant Disorder, Conduct Disorder in Adulthood
- High Suicidality Among Children With ADHD Mediated by Family Functioning, Psychiatry Comorbidities
- Pilot Study Investigates Lithium vs Quetiapine for Bipolar Spectrum Disorder
- How Personalized Hospital Ratings May Drive Patient-Specific Care in the Digital Age